在预测社区居住的老年人的身体表现下降或死亡率方面,Phenoage和Phenoageaccel的表现并不优于时间年龄
Maria Serena Iuorio1,2, Antonio De Vincentis1,3, Diana Lelli1
1Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, Roma, 00128, Italy.
概括
年代学年龄更好地预测了老年人的身体衰退和死亡率,而不是像PhenoAge这样的生物年龄指标. 这些生物标志物虽然与不良结果有关,但在一般人群中没有提供额外的预测能力.
科学领域:
- 老年学是指老年学的学科.
- 生物标志物 生物标志物
- 公共卫生 公共卫生
背景情况:
- 年代年龄是个体衰老和功能衰退的不良指标.
- 生物年龄指标 (PhenoAge,PhenoAgeAccel) 是有前途的,但它们对社区老年人的身体表现的预测效用尚不清楚.
研究的目的:
- 为了评估时间学年龄,PhenoAge和PhenoAgeAccel对老年人身体功能下降和死亡率的预测值.
- 为了比较这些指标在预测最初正常身体表现的个体的功能衰退中的表现.
主要方法:
- 来自InCHIANTI研究的979名社区老年人 (≥65岁) 的数据分析.
- 线性混合和考克斯模型评估了时间学年龄,PhenoAge,PhenoAgeAccel (z-scores) 和身体功能纵向变化 (重新调整的SPPB) 和10年死亡率之间的关联.
- 二次分析预测了使用AUC和AIC的身体功能受损 (SPPB ≤9) 的出现.
主要成果:
- 所有与增加身体功能下降和死亡率相关的指标.
- 时间学年龄与身体功能下降 (β = -0.41) 和死亡率 (HR = 2.78) 的关联最强.
- 与时间学年龄相比,PhenoAge和PhenoAgeAccel对身体衰退的相关性较弱,预测精度 (AUC) 较低.
结论:
- PhenoAge和PhenoAgeAccel与老年人的不良功能结果有关.
- 这些生物年龄指标没有提供超越年代年龄的功能衰退和一般老年人口死亡率的额外预测价值.
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
174
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
174
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
216
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
216
Drug Dosing: Geriatric Patients
206
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
206
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
209
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
209
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
178
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
178
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
205
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
205


